MIA's annual Research Retreat 2021
20 August 2021
Today Melanoma Institute Australia (MIA) held its annual Research Retreat with more than 150 clinicians, researchers and MIA staff gathering online for a virtual event.
The Retreat shared highlights from MIA-led research activities as we continue to work towards our mission of zero deaths from melanoma.
Despite the constraints of COVID, research has continued to drive advances in melanoma treatment, detection, prevention and supportive care, as well as focusing on society, policy and economic impacts.
MIA's research is grouped into four themes:
- Early Melanoma - led by Prof Richard Scolyer AO and A/Prof Sydney Ch'ng
- Advanced Melanoma - led by Prof Georgina Long AO and Prof Helen Rizos
- Prevention, Risk and Clinical Detection - led by Prof Anne Cust and Prof Pascale Guitera
- Supportive Care and Survivorship - led by Dr Iris Batula and A/Prof Robyn Saw
- Society, Policy and Economics - led by Prof Rachael Morton & A/Prof Alex Menzies
Given our proud reputation as a world leader in melanoma research, it was appropriate that today’s inspiring program of presentations included a panel discussion on developing the next generation of melanoma research leaders.
Many thanks to our many research collaborators.
Read recently published research publications by the MIA team here.
Read about some of our active MIA research projects here.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.